Results 11 to 20 of about 16,340 (253)
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
Hepatology, 2021 Locoregional therapies, including yttrium‐90 radioembolization, play an important role in the treatment of unresectable HCC. The aim of the LEGACY (Local radioEmbolization using Glass Microspheres for the Assessment of Tumor Control with Y‐90) study was ...
R. Salem +8 more
semanticscholar +1 more source
Radiology, 2022 Background Transarterial chemoembolization (TACE) is the recommended treatment for intermediate hepatocellular carcinoma (HCC) according to the Barcelona Clinic Liver Cancer guidelines.
E. Dhondt +12 more
semanticscholar +1 more source
Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma. [PDF]
PLoS ONE, 2017 Radioembolization for the treatment of hepatocellular carcinoma (HCC) induces liver volume changes referred to as "atrophy-hypertrophy complex". The aim of this study was to investigate lobar liver volume changes after unilateral radioembolization and to
Juliane Goebel +8 more
doaj +1 more source
Lung Shunt Reduction for Yttrium-90 Radioembolization: ChemoembolizationVersusRadioembolization [PDF]
In Vivo, 2021 To evaluate the efficacy of chemoembolization versus radioembolization in reducing lung shunt fraction (LSF) in patients with hepatocellular carcinoma (HCC).In this retrospective study, from March 2012 to January 2021, 457 patients with HCC underwent planning angiography and 99mTc-macroaggregated albumin imaging for possible yttrium-90 ...
Hyo-Cheol, Kim +5 more
openaire +2 more sources
Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma
Journal of Gastrointestinal Oncology, 2023 Background Yttrium-90 (Y90) radioembolization is a catheter-based therapy for hepatocellular carcinoma (HCC). Multiple trials have evaluated the efficacy of Y90 in HCC; however, few have assessed long-term hepatic function. This study aimed to evaluate a
Hannah Lee +6 more
semanticscholar +1 more source
Liver Research, 2021 Patients with recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) have a poor prognosis owing to rapid tumor progression.
Jian-Wen Zhang +6 more
doaj +1 more source
Clinical Cancer Research, 2023 PURPOSE Synergistic effect of radiotherapy and immunotherapy for the treatment of hepatocellular carcinoma (HCC) has been reported. This phase 1/2a pilot trial evaluated preliminary efficacy and safety of combination of radioembolization with yttrium-90 ...
Y. Lee +8 more
semanticscholar +1 more source
Cancers, 2023 Simple Summary The usefulness of transarterial radioembolization (TARE) as a treatment has been endorsed by different authors and recommended by a multidisciplinary working group in terms of its safety, efficacy and feasibility for the surgical resection
V. López-López +13 more
semanticscholar +1 more source
Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with Y microspheres [PDF]
Clinical and Molecular Hepatology, 2014 Transcatheter arterial radioembolization (TARE) with Yttrium-90 (90Y)-labeled microspheres has an emerging role in treatment of patients with unresectable hepatocellular carcinoma.
Sun Young Yim +10 more
doaj +1 more source
Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study
Frontiers in Oncology, 2023 Objective To report the incidence of radiation pneumonitis after radioembolization. Methods In this retrospective study, from May 2009 to July 2021, 782 consecutive patients underwent radioembolization in two institutes.
Hyo-Choel Kim, G. Kim
semanticscholar +1 more source